20% Special Sale Ends Today! Hurry Up!!!

Cameroon Malaria Vaccine Program

Cameroon Malaria Vaccine Program mind map
Recent News
January 2024 Launch
When
Launched January 2024
Why
Combat Malaria
What
RTS,S Vaccine
Developed by GSK
Targets P. falciparum
Four Doses
From 5 Months Age
Where
Across Cameroon
Who
Cameroon Government
Supported by
WHO
Gavi
UNICEF
How
Free of Charge
Integrated with Other Vaccinations
20 African Countries Involved
Significance
First of Its Kind
Reduces Severe Malaria Risk
Alleviates Healthcare Burden
Challenges
Moderate Effectiveness
Logistical Challenges
Requires Multiple Doses
Way Forward
Broader African Rollout
Introduction of Second Vaccine
R21 by Oxford University

In January 2024, Cameroon launched the world’s first malaria vaccine program for children, marking a significant milestone in public health. The program utilizes the RTS,S vaccine, developed by GSK, to target the deadliest strain of malaria, P. falciparum. This vaccine, which requires four doses starting from around 5 months of age, will be offered free of charge and integrated with other routine child immunizations. While the vaccine’s effectiveness is moderate, it represents a critical step towards reducing the malaria burden in Africa, where the disease has a profound impact. Challenges such as logistical distribution and ensuring complete immunization remain, but the program’s launch is seen as a major achievement in the fight against malaria.

Related Posts

Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments
X
Home Courses Plans Account
20% Special Sale Ends Today! Hurry Up!!!